Results of a phase 1/2 study for KW-0761, a monoclonal antibody directed against CC chemokine receptor type 4 (CCR4), in CTCL patients

Authors
Category Primary study
JournalMelanoma Research
Year 2011
This article has no abstract
Epistemonikos ID: e6480f7a998620acb9b6c8bc1ee0c3bef243d171
First added on: Feb 05, 2025